FDA Approves Caplyta for Major Depressive Disorder in Adults
Published on November 13, 2025 at 11:41PM by Drugs.com - Daily MedNews
THURSDAY, Nov. 13, 2025 -- The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks the fourth indication...
Read the original article here: https://www.drugs.com/news/fda-approves-caplyta-major-depressive-disorder-adults-127543.html